Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 478973, 11 pages
http://dx.doi.org/10.1155/2014/478973
Research Article

Antihypercholesterolemic and Antioxidative Potential of an Extract of the Plant, Piper betle, and Its Active Constituent, Eugenol, in Triton WR-1339-Induced Hypercholesterolemia in Experimental Rats

1Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamilnadu 620024, India
2Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirappalli, Tamilnadu 620001, India

Received 31 October 2013; Accepted 16 December 2013; Published 9 January 2014

Academic Editor: Mao-Hsiung Yen

Copyright © 2014 Karuppasamy Venkadeswaran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Morsy and A. A. Fouad, “Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats,” Phytotherapy Research, vol. 22, no. 10, pp. 1361–1366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Freedman, “High-fat diets and cardiovascular disease: are nutritional supplements useful?” Journal of the American College of Cardiology, vol. 41, no. 10, pp. 1750–1752, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Jain, R. R. Kulkarni, and D. P. Jain, “Current drug targets for antihyperlipidemic therapy,” Mini Reviews in Medicinal Chemistry, vol. 10, no. 3, pp. 232–262, 2010. View at Google Scholar · View at Scopus
  4. Å. L. Amundsen, L. Ose, M. S. Nenseter, and F. Y. Ntanios, “Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia,” American Journal of Clinical Nutrition, vol. 76, no. 2, pp. 338–344, 2002. View at Google Scholar · View at Scopus
  5. T. Ichihashi, M. Izawa, K. Miyata, T. Mizui, K. Hirano, and Y. Takagishi, “Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption,” Journal of Pharmacology and Experimental Therapeutics, vol. 284, no. 1, pp. 43–50, 1998. View at Google Scholar · View at Scopus
  6. W. Shi, M. E. Haberland, M.-L. Jien, D. M. Shih, and A. J. Lusis, “Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice,” Circulation, vol. 102, no. 1, pp. 75–81, 2000. View at Google Scholar · View at Scopus
  7. D. L. Tribble, “Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and β-carotene: a statement for healthcare professionals from the American Heart Association,” Circulation, vol. 99, no. 4, pp. 591–595, 1999. View at Google Scholar · View at Scopus
  8. E. Hopps, D. Noto, G. Caimi, and M. R. Averna, “A novel component of the metabolic syndrome: the oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 1, pp. 72–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. M. F. Duarte, J. B. T. Rocha, R. N. Moresco et al., “Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia,” Clinical Biochemistry, vol. 42, no. 7-8, pp. 666–671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Ahmad, Z. Mehmood, and F. Mohammad, “Screening of some Indian medicinal plants for their antimicrobial properties,” Journal of Ethnopharmacology, vol. 62, no. 2, pp. 183–193, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. R. S. Koff, G. Gordan, and S. M. Sabesin, “D-Galactosamine hepatitis hepatocellular injury and fatty liver following a single dose,” Proceedings of the Society for Experimental Biology and Medicine, vol. 137, pp. 696–701, 1971. View at Google Scholar
  12. D. Chakraborty and B. Shah, “Antimicrobial, anti-oxidative and anti-hemolytic activity of Piper betel leaf extracts,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 3, pp. 192–199, 2011. View at Google Scholar · View at Scopus
  13. E. Nagababu and N. Lakshmaiah, “Inhibitory effect of eugenol on non-enzymatic lipid peroxidation in rat liver mitochondria,” Biochemical Pharmacology, vol. 43, no. 11, pp. 2393–2400, 1992. View at Publisher · View at Google Scholar
  14. H. Kabuto, M. Tada, and M. Kohno, “Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum,” Biological and Pharmaceutical Bulletin, vol. 30, no. 3, pp. 423–427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. World Health Organization, “FAO/WHO expert committee on food additives evaluation of certain food additives and contaminants,” Tech. Rep. 683, WHO, Geneva, Switzerland, 1982. View at Google Scholar
  16. A. M. Rimando, B. H. Han, J. H. Park, and M. C. Cantoria, “Studies on the constituents of Philippine Piper betle leaves,” Archives of Pharmacal Research, vol. 9, no. 2, pp. 93–97, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Manigauha, S. Patel, H. Ali, A. Chandy, and M. Uma Maheshwari, “Study the effect of phytochemical constituents of Piper betle leaves extracts on liver disorders by in vivo model,” Journal of Pharmacy Research, vol. 2, pp. 353–356, 2009. View at Google Scholar
  18. P. E. Schurr, J. R. Schultz, and T. M. Parkinson, “Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs,” Lipids, vol. 7, no. 1, pp. 68–74, 1972. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  20. T. Sasaki, S. Matzy, and A. Sonal, “Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation,” Rinsho Kagaku, vol. 1, pp. 346–353, 1972. View at Google Scholar
  21. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  22. J. King, “The transferases-alanine and aspartate transaminases,” in Practical Clinical Enzymology, D. Van, Ed., pp. 121–138, D. Van Nostrand, London, UK, 1965. View at Google Scholar
  23. J. King, “The hydrolases-acid and alkaline phosphatases,” in Practical Clinical Enzymology, D. Van, Ed., pp. 191–208, D. Van Nostrand, London, UK, 1965. View at Google Scholar
  24. J. King, “The dehydrogenases or oxidoreductases lactate dehydrogenase,” in Practical Clinical Enzymology, D. Van, Ed., D. Van Nostrand, London, UK, 1965. View at Google Scholar
  25. A. K. Sinha, “Colorimetric assay of catalase,” Analytical Biochemistry, vol. 47, no. 2, pp. 389–394, 1972. View at Google Scholar · View at Scopus
  26. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry, vol. 47, no. 3, pp. 469–474, 1974. View at Google Scholar · View at Scopus
  27. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, “Selenium: biochemical role as a component of glatathione peroxidase,” Science, vol. 179, no. 4073, pp. 588–590, 1973. View at Google Scholar · View at Scopus
  28. W. H. Habig and W. B. Jakoby, “[51] Assays for differentiation of glutathione S-Transferases,” Methods in Enzymology, vol. 77, pp. 398–405, 1981. View at Publisher · View at Google Scholar · View at Scopus
  29. M. S. Moron, J. W. Depierre, and B. Mannervik, “Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver,” Biochimica et Biophysica Acta, vol. 582, no. 1, pp. 67–78, 1979. View at Google Scholar · View at Scopus
  30. S. T. Omaye, J. David Turnbull, and H. E. Sauberlich, “[1] Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids,” Methods in Enzymology, vol. 62, pp. 3–11, 1979. View at Publisher · View at Google Scholar · View at Scopus
  31. I. D. Desai, “Vitamin E analysis methods for animal tissues,” Methods in Enzymology, vol. 105, pp. 138–147, 1984. View at Google Scholar · View at Scopus
  32. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  33. R. A. B. Drury and E. A. Wallington, Wallington, Carleton’s Histological Technique, Oxford University Press, New York, NY, USA, 1980.
  34. S. O. Byers, M. Fiedman, and T. Sugiyama, “Triton hypercholesteremia: cause or consequence of augmented cholesterol synthesis,” The American Journal of Physiology, vol. 204, pp. 1100–1102, 1963. View at Google Scholar · View at Scopus
  35. H. Harnafi, H. Serghini Caid, N. el Houda Bouanani, M. Aziz, and S. Amrani, “Hypolipemic activity of polyphenol-rich extracts from Ocimum basilicum in Triton WR-1339-induced hyperlipidemic mice,” Food Chemistry, vol. 108, no. 1, pp. 205–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Ansarullah, R. Jadeja, M. Thounaojam, V. Patel, R. Devkar, and A. Ramachandran, “Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339 (Tyloxapol) induced hyperlipidemia: a comparison with lovastatin,” International Journal of Green Pharmacy, vol. 3, no. 2, pp. 119–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Vijayaraj, K. Muthukumar, J. Sabarirajan, and V. Nachiappan, “Antihyperlipidemic activity of Cassia auriculata flowers in triton WR 1339 induced hyperlipidemic rats,” Experimental and Toxicologic Pathology, no. 1-2, pp. 135–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S.-J. Lee, J.-H. Ko, K. Lim, and K.-T. Lim, “150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse,” Pharmacological Research, vol. 51, no. 5, pp. 399–408, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Shattat, R. Al-Qirim, Y. Al-Hiari et al., “Synthesis and anti-hyperlipidemic evaluation of N-(benzoylphenyl)-5-fluoro- 1H-indole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats,” Molecules, vol. 15, no. 9, pp. 5840–5849, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Shattat, T. Al-Qirim, K. Sweidan, M. Shahwan, W. El-Huneidi, and Y. Al-Hiari, “The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 25, no. 6, pp. 751–755, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. J. Ågren, J.-P. Kurvinen, and A. Kuksis, “Isolation of very low density lipoprotein phospholipids enriched in ethanolamine phospholipids from rats injected with Triton WR 1339,” Biochimica et Biophysica Acta, vol. 1734, no. 1, pp. 34–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. P. R. Holt and A. A. Dominguez, “Triton-induced hyperlipidemia: a model for studies of intestinal lipoprotein production,” The American Journal of Physiology, vol. 238, no. 5, pp. G453–G457, 1980. View at Google Scholar · View at Scopus
  43. A. K. Khanna, F. Rizvi, and R. Chander, “Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats,” Journal of Ethnopharmacology, vol. 82, no. 1, pp. 19–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Davey Smith and J. Pekkanen, “Should there be a moratorium on the use of cholesterol lowering drugs?” British Medical Journal, vol. 304, no. 6824, pp. 431–434, 1992. View at Google Scholar · View at Scopus
  45. M. J. Malloy and J. P. Kane, “Medical management of hyperlipidemic states,” Advances in Internal Medicine, vol. 39, pp. 603–631, 1994. View at Google Scholar · View at Scopus
  46. J. E. Hokanson and M. A. Austin, “Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies,” Journal of Cardiovascular Risk, vol. 3, no. 2, pp. 213–219, 1996. View at Google Scholar · View at Scopus
  47. M. A. Austin, J. E. Hokanson, and J. D. Brunzell, “Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance,” Current Opinion in Lipidology, vol. 5, no. 6, pp. 395–403, 1994. View at Google Scholar · View at Scopus
  48. T. Murakami, S. Michelagnoli, R. Longhi et al., “Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 11, pp. 1819–1828, 1995. View at Google Scholar · View at Scopus
  49. M. J. Thomas, “Physiological aspects of low density lipoprotein oxidation,” Current Opinion in Lipidology, vol. 11, pp. 297–301, 2000. View at Google Scholar
  50. I. Vallianou, N. Peroulis, P. Pantazis, and M. Hadzopoulou-Cladaras, “Camphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activity,” PLoS ONE, vol. 6, no. 11, Article ID e20516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Küçükgergin, A. F. AydIn, G. Özdemirler-Erata, G. Mehmetçik, N. Koçak-Toker, and M. Uysal, “Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet,” Biological Trace Element Research, vol. 135, no. 1–3, pp. 264–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. D. W. Molander, F. Wroblewski, and J. S. ladue, “Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity,” Journal of Laboratory and Clinical Medicine, vol. 6, pp. 831–839, 1955. View at Google Scholar
  53. R. Anandhi, T. Annadurai, T. S. Anitha et al., “Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats,” Journal of Physiology and Biochemistry, vol. 69, no. 2, pp. 313–323, 2013. View at Publisher · View at Google Scholar
  54. K. Prasad, “Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed,” Circulation, vol. 99, no. 10, pp. 1355–1362, 1999. View at Google Scholar · View at Scopus
  55. B. Halliwell, “Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?” Cardiovascular Research, vol. 47, no. 3, pp. 410–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. C. G. Sheela and K. T. Augusti, “Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn and gugulipid in cholesterol diet fed rats,” Indian Journal of Experimental Biology, vol. 33, no. 5, pp. 337–341, 1995. View at Google Scholar · View at Scopus
  57. C. D. Klaassen, W. M. Bracken, R. E. Dudley, P. L. Goering, G. A. Hazelton, and J. J. Hjelle, “Role of sulfhydryls in the hepatotoxicity of organic and metallic compounds,” Toxicological Sciences, vol. 5, no. 5, pp. 806–815, 1985. View at Publisher · View at Google Scholar · View at Scopus
  58. M. G. Traber and H. Sies, “Vitamin E in humans: demand and delivery,” Annual Review of Nutrition, vol. 16, pp. 321–347, 1996. View at Google Scholar · View at Scopus
  59. B. A. Freeman and J. D. Crapo, “Biology of disease. Free radicals and tissue injury,” Laboratory Investigation, vol. 47, no. 5, pp. 412–426, 1982. View at Google Scholar · View at Scopus
  60. K. Prasad and J. Kalra, “Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E,” American Heart Journal, vol. 125, no. 4, pp. 958–973, 1993. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Niki, H. Shimasaki, and M. Mino, Antioxidant-Free Radical and Biological Defence, Gakkai-Shuppan Center, Tokyo, Japan, 1994.
  62. P. R. Deepa and P. Varalakshmi, “Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis,” Clinica Chimica Acta, vol. 339, no. 1-2, pp. 105–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. V. Sudhahar, S. A. Kumar, and P. Varalakshmi, “Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia,” Life Sciences, vol. 78, no. 12, pp. 1329–1335, 2006. View at Publisher · View at Google Scholar · View at Scopus